These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 24111645

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries.
    Caballero T, Aberer W, Longhurst HJ, Maurer M, Zanichelli A, Perrin A, Bouillet L, Andresen I, IOS Study Group.
    J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):1214-1222. PubMed ID: 28370444
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Management of acute attacks of hereditary angioedema: potential role of icatibant.
    Longhurst HJ.
    Vasc Health Risk Manag; 2010 Sep 07; 6():795-802. PubMed ID: 20859548
    [Abstract] [Full Text] [Related]

  • 28. Bradykinin B2 receptor antagonist off label use in short-term prophylaxis in hereditary angioedema.
    Angeletti C, Angeletti PM, Mastrobuono F, Pilotti L, Ciccozzi A, Guetti C.
    Int J Immunopathol Pharmacol; 2014 Sep 07; 27(4):653-9. PubMed ID: 25572747
    [Abstract] [Full Text] [Related]

  • 29. Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.
    Prescrire Int; 2010 Nov 07; 19(110):245-7. PubMed ID: 21284353
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results].
    Kawalec P, Holko P, Paszulewicz A, Obtułowicz K.
    Pneumonol Alergol Pol; 2013 Nov 07; 81(2):95-104. PubMed ID: 23420425
    [Abstract] [Full Text] [Related]

  • 32. Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.
    Zanichelli A, Bova M, Coerezza A, Petraroli A, Triggiani M, Cicardi M.
    Allergy; 2012 Aug 07; 67(8):1074-7. PubMed ID: 22686628
    [Abstract] [Full Text] [Related]

  • 33. Population Pharmacokinetics and Exposure-Response Analyses to Guide Dosing of Icatibant in Pediatric Patients With Hereditary Angioedema.
    Wang Y, Jomphe C, Marier JF, Martin P.
    J Clin Pharmacol; 2021 Apr 07; 61(4):555-564. PubMed ID: 33091166
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
    Baş M, Greve J, Stelter K, Havel M, Strassen U, Rotter N, Veit J, Schossow B, Hapfelmeier A, Kehl V, Kojda G, Hoffmann TK.
    N Engl J Med; 2015 Jan 29; 372(5):418-25. PubMed ID: 25629740
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years.
    Farkas H, Kőhalmi KV.
    Expert Rev Clin Immunol; 2018 Jun 29; 14(6):447-460. PubMed ID: 29757016
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.